Pharming (PHAR) Acquisitions (2019 - 2025)

Pharming (PHAR) posted Acquisitions of -$57.5 million for Q4 2025, down 131.11% on a QoQ basis from $184.8 million in Q1 2023.

Pharming (PHAR) Acquisitions (2019 - 2025) Analysis & Trends

Pharming's Acquisitions history runs 6 years deep, the most recent figure standing at -$57.5 million for Q4 2025.

Quarterly Acquisitions changed N/A year-over-year to -$57.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$62.4 million (changed N/A YoY) and the FY2025 annual result came in at -$57.5 million, changed N/A from the prior year.
Acquisitions was -$57.5 million for Q4 2025 at Pharming, down from $184.8 million in the prior quarter.
Across five years, Acquisitions topped out at $206.6 million in Q1 2021 and bottomed at -$190.0 million in Q3 2022.
A 4-year average of $37.3 million and a median of $290000.0 in 2022 frame the typical range for Acquisitions.
Peak annual rise in Acquisitions reached 0.04% in 2021, while the deepest fall reached 33024.99% in 2021.
Pharming's Acquisitions stood at -$547000.0 in 2021, then sank by 34628.34% to -$190.0 million in 2022, then surged by 197.27% to $184.8 million in 2023, then sank by 131.11% to -$57.5 million in 2025.
Business Quant data shows PHAR's Acquisitions at -$57.5 million in Q4 2025, $184.8 million in Q1 2023, and -$190.0 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Pharming	9.02 Bn	8.96 Bn	65.80 Mn	-

Download Data